close
This ad will auto close in 10 seconds

Sun Pharmaceutical in talks to buy Meda for over $5 bn: Report

The pharma company’s stocks last traded down 2.54% at Rs 1,045.50 for the week ended yesterday.



Zee Media Bureau

Mumbai: Sun Pharmaceutical Industries Ltd is in talks to buy Sweden's Meda AB for over USD 5 billion, a news wire has reported.

Sun Pharma has reported a 23.32 percent increase in consolidated net profit for the January-March quarter.

The pharma company’s stocks last traded down 2.54% at Rs 1,045.50 for the week ended yesterday.

Mumbai-based Sun is India's most valuable drugmaker, with a market capitalisation of some USD 20 billion, and has made several acquisitions in recent years.

With Agency Inputs

From Zee News

0 Comment - Join the Discussions